首頁/股票/LXRX

LXRX

USD

Lexicon Pharmaceuticals Inc. Common Stock

$1.340+0.010 (0.752%)

即時價格

Healthcare

生物科技

美國

價格圖表

Loading Chart...

關鍵指標

市場指標

公司基本面

交易統計

市場指標

開盤

$1.330

最高

$1.390

最低

$1.325

交易量

2.72M

公司基本面

市值

487.0M

行業

生物科技

國家

United States

交易統計

平均交易量

2.36M

交易所

NCM

貨幣

USD

52週範圍

最低 $0.28當前 $1.340最高 $1.66

相關新聞

2025年11月4日 · 下午01:30

GlobeNewswire

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans

THE WOODLANDS, Texas, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced that data from three studies of sotagliflozin will be presented during upcoming medical meetings. Two

Data Demonstrating Unique Benefits of Sotagliflozin in Diverse Patient Populations will be Presented at the Hypertrophic Cardiomyopathy Society and American Heart Association's Sessions 2025 in New Orleans

2025年10月30日 · 下午12:30

GlobeNewswire

Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025

THE WOODLANDS, Texas, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) today announced the Company will release its third quarter 2025 financial results on Thursday, November 6, 2025, prior